1Weinhandl ED,Foley RN,Gilbertson DT,et al.Propensitymatched mortality comparison of incident hemodialysis and peritoneal dialysis patients[J].J Am Soc Nephrol,2010,21:499-506.
2Paniagua R,Amato D,Vonesh E,et al.Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis:ADEMEX,a prospective,randomized,controlled trial[J].J Am Soc Nephrol,2002,13:1307-1320.
3Lo WK,Ho YW,Li CS,et al.Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study[J].Kidney Int,2003,64:649-656.
4Lo WK,Bargman JM,Burkart J,et al.Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis[J].Perit Dial Int,2006,26:520-522.
5Dombros N,Dratwa M,Feriani M,et al.European best practice guidelines for peritoneal dialysis.7 Adequacy of peritoneal dialysis[J].Nephrol Dial Transplant,2005,20 Suppl 9:ix24-ix27.
6Brunkhorst R.Hypervolemia,arterial hypertension and cardiovascular disease:a largely neglected problem in peritoneal dialysis[J].Clin Nephrol,2008,69:233-238.
7Stegmayr BG.Ultrafiltration and dry weight-what are the cardiovascular effects?[J].Artif Organs,2003,27:227-229.
8Lin A,Qian J,Li X,et al.Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid[J].Clin J Am Soc Nephrol,2009,4:1799-1804.
9Davies SJ,Woodrow G,Donovan K,et al.Icodextrin improves the fluid status of peritoneal dialysis patients:results of a double-blind randomized controlled trial[J].J Am Soc Nephrol,2003,14:2338-2344.
10Furuya R,Odamaki M,Kumagai H,et al.Beneficial effects of icodextrin on plasma level of adipocytokines in peritoneal dialysis patients[J].Nephrol Dial Transplant,2006,21:494-498.
3Tam P. Peritoneal dialysis and preservation of residual renal function [ J ]. Petit Dial Int,2009,29 ( Suppl 2 ) : S 108 - S110.
4Schaubel DE, Blake PG, Fenton SS. Effect of renal center character- istics on mortality and technique failure on peritoneal dialysis [ J ]. Kidney Int,2001,60(4) :1517 -1524.
